Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease
Top Cited Papers
Open Access
- 11 April 2025
- journal article
- review article
- Published by Elsevier in JHEP Reports
- Vol. 7 (8) , 101421
Abstract
No abstract availableKeywords
Funding Information
- German Research Foundation (Ta434/8-1, CRC1382 Project-ID 403224013)
- National Institute of Diabetes and Digestive and Kidney Diseases (5P30DK132710, 5R01DK128289, 5R44DK125191)
- Columbia University (5R01DK128289, 5P30DK132710, 5R44DK125191)
- National Cancer Institute Division of Cancer Prevention
This publication has 426 references indexed in Scilit:
- GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseJAMA Internal Medicine, 2024
- Extracellular vesicles originating from steatotic hepatocytes promote hepatic stellate cell senescence via AKT/mTOR signalingCell Biochemistry and Function, 2024
- Serum CCL24 as a Biomarker of Fibrotic and Vascular Disease Severity in Systemic SclerosisArthritis Care & Research, 2024
- BMP9 and BMP10: Two close vascular quiescence partners that stand outDevelopmental Dynamics, 2021
- Reduction of Advanced Liver Fibrosis by Short-Term Targeted Delivery of An Angiotensin Receptor Blocker to Hepatic Stellate Cells in RatsHepatology, 2009
- Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitisHepatology, 2007
- In vivo immune modulatory activity of hepatic stellate cells in miceHepatology, 2006
- Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†Hepatology, 2005
- Inhibition of T–Cell Responses by Hepatic Stellate Cells Via B7–H1-Mediated T–Cell Apoptosis in MiceHepatology, 2004
- P38 Mapk Mediates Fibrogenic Signal Through Smad3 Phosphorylation in Rat MyofibroblastsHepatology, 2003